Transgenic mice expressing human CD20 and/or CD16
US7402728B2 · kind B2 · utility
16Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2003 |
| Grant date | Jul 22, 2008 |
| Priority date | — |
| Expiry date | Jan 3, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/507
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to non-human transgenic animals expressing human cellular markers, including CD20 and/or preferably CD16.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.